XML 24 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2013
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents revenues, gross profit and operating income by reportable segment (in thousands):
 
Three Months Ended
 
March 31,
 
2013
 
2012
Revenues:
 
 
 
Apex
$
212,728

 
$
—

Oxford
95,262

 
78,759

Life Sciences
40,473

 
41,351

Physician
26,302

 
24,089

Healthcare
14,428

 
12,561

 
$
389,193

 
$
156,760

Gross Profit:
 
 
 
Apex
$
55,619

 
$
—

Oxford
32,150

 
27,370

Life Sciences
13,384

 
13,839

Physician
7,483

 
7,499

Healthcare
4,638

 
4,041

 
$
113,274

 
$
52,749

Operating Income (Loss):
 
 
 
Apex
$
10,079

 
$
—

Oxford
11,405

 
7,235

Life Sciences
692

 
2,308

Physician
2,154

 
1,078

Healthcare
(596
)
 
(1,251
)
 
$
23,734

 
$
9,370
Schedule of Revenue by Geographical Areas
The Company operates internationally, with operations mainly in the United States, Europe, Canada, Australia and New Zealand. The following table presents domestic and foreign revenues (in thousands):

 
Three Months Ended
 
March 31,
 
2013
 
2012
Revenues:
 
 
 
Domestic
$
368,797

 
$
137,444

Foreign
20,396

 
19,316

 
$
389,193

 
$
156,760
Reconciliation of Assets from Segment to Consolidated
The Company does not report Life Sciences and Healthcare segments’ total assets separately as the field operations are largely combined. The following table presents total assets as allocated by reportable segment (in thousands):

 
March 31,
2013
 
December 31, 2012
Total Assets:
 
 
 
Apex
$
647,463

 
$
642,594

Oxford
235,846

 
231,211

   Life Sciences and Healthcare
127,431

 
139,601

Physician
82,696

 
84,615

 
$
1,093,436

 
$
1,098,021